MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ZYME has $397,269K in assets. $77,205K in debts. $64,834K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
693.84%
Cash Ratio
154.21%
Debt to Asset Ratio
19.43%
Assets Breakdown
    • Short-term marketable securities...
    • Cash and cash equivalents
    • Long-term marketable securities ...
    • Others
Liabilities Breakdown
    • Common stock, 0.00001 par value ...
    • Accumulated deficit
    • Additional paid-in capital
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
64,834 98,253
Short-term marketable securities (note 5)
187,099 183,126
Accounts receivable
29,352 2,631
Prepaid expenses and other current assets
10,427 12,120
Total current assets
291,712 296,130
Long-term marketable securities (note 5)
47,427 51,996
Long-term prepaids and other assets
7,388 8,855
Deferred tax asset
4,862 4,769
Property and equipment, net
15,819 16,314
Operating lease right-of-use assets
16,648 16,260
Intangible assets, net
1,397 2,045
Goodwill (note 6)
12,016 12,016
Total assets
397,269 408,385
Accounts payable and accrued liabilities (note 7)
34,430 31,003
Income tax payable
1,016 102
Current portion of operating lease liability (note 11)
3,400 3,586
Deferred revenue (note 9)
3,197 3,811
Total current liabilities
42,043 38,502
Long-term portion of operating lease liability (note 11)
15,504 15,092
Deferred revenue (note 9)
14,607 14,607
Other long-term liabilities (note 7)
278 828
Deferred tax liability
4,773 4,850
Total liabilities
77,205 73,879
Common stock, 0.00001 par value 900,000,000 authorized shares at september30, 2025 and december31, 2024, respectively 75,139,281 and 68,964,319 shares issued and outstanding at september30, 2025 and december31, 2024, respectively (note 8a)
1,092,929 1,074,079
Exchangeable shares, no par value, 569,189 and 570,637 issued and outstanding shares at september30, 2025 and december31, 2024, respectively (note 8a)
8,168 8,178
Additional paid-in capital
111,489 109,243
Accumulated other comprehensive loss
-6,050 -6,340
Accumulated deficit
-886,472 -850,654
Total stockholders equity
320,064 334,506
Total liabilities and stockholders equity
397,269 408,385
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$10,427K Accounts receivable$29,352K Short-term marketablesecurities (note 5)$187,099K Cash and cashequivalents$64,834K Goodwill (note 6)$12,016K Intangible assets, net$1,397K Operating leaseright-of-use assets$16,648K Property and equipment,net$15,819K Deferred tax asset$4,862K Long-term prepaids andother assets$7,388K Long-term marketablesecurities (note 5)$47,427K Total current assets$291,712K Total assets$397,269K Total liabilities andstockholders equity$397,269K Total stockholdersequity$320,064K Total liabilities$77,205K Accumulated deficit-$886,472K Accumulated othercomprehensive loss-$6,050K Additional paid-in capital$111,489K Exchangeable shares, no parvalue, 569,189 and...$8,168K Common stock, 0.00001par value...$1,092,929K Deferred tax liability$4,773K Other long-termliabilities (note 7)$278K Deferred revenue (note 9)$14,607K Long-term portion ofoperating lease liability...$15,504K Total currentliabilities$42,043K Deferred revenue (note 9)$3,197K Current portion ofoperating lease liability...$3,400K Income tax payable$1,016K Accounts payable andaccrued liabilities...$34,430K

Zymeworks Inc. (ZYME)

Zymeworks Inc. (ZYME)